HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Massari Selected Research

cabozantinib

10/2022Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.
2/2022Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors.
1/2022Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.
1/2022Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis.
1/2022Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
1/2022Cabozantinib for Treatment of Brain Metastases in Patients With Renal Cell Carcinoma.
12/2021An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma.
1/2021Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
1/2021Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
10/2020Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Massari Research Topics

Disease

102Neoplasms (Cancer)
11/2022 - 12/2013
100Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 06/2013
70Prostatic Neoplasms (Prostate Cancer)
05/2022 - 07/2013
37Neoplasm Metastasis (Metastasis)
04/2022 - 09/2004
31Carcinoma (Carcinomatosis)
12/2022 - 12/2009
17Urinary Bladder Neoplasms (Bladder Cancer)
03/2021 - 01/2015
12Pain (Aches)
11/2020 - 01/2004
10Heart Failure
05/2022 - 11/2002
10Circulating Neoplastic Cells
01/2021 - 01/2017
7Aneurysm (Aneurysms)
11/2022 - 03/2016
6Kidney Neoplasms (Kidney Cancer)
10/2022 - 07/2013
6Breast Neoplasms (Breast Cancer)
02/2021 - 11/2007
6Inflammation (Inflammations)
01/2020 - 01/2014
6Adenocarcinoma
01/2018 - 08/2006
5Melanoma (Melanoma, Malignant)
03/2022 - 01/2018
5Disease Progression
05/2020 - 07/2015
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 07/2011
5Compression Fractures (Compression Fracture)
09/2009 - 01/2004
4Carcinogenesis
11/2022 - 01/2015
4Lung Neoplasms (Lung Cancer)
03/2022 - 03/2013
4Infections
01/2021 - 01/2004
4Stroke (Strokes)
01/2021 - 06/2013
4Pulmonary Embolism
07/2008 - 01/2004
4Intractable Pain
07/2008 - 01/2004
3Pathologic Constriction (Stenosis)
05/2022 - 06/2013
3Hypothyroidism
02/2022 - 01/2019
3Drug-Related Side Effects and Adverse Reactions
01/2022 - 05/2021
3Noninfiltrating Intraductal Carcinoma (DCIS)
03/2021 - 01/2017
3Hemorrhage
01/2021 - 05/2016
3Urogenital Neoplasms
09/2016 - 11/2014
3Hemangioma (Angioma)
10/2014 - 10/2004
3Neurologic Manifestations (Neurological Manifestations)
07/2008 - 10/2004
3Osteoporosis
07/2005 - 03/2004
2Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula)
09/2022 - 08/2020
2Embolism (Embolus)
06/2022 - 01/2021
2Hepatocellular Carcinoma (Hepatoma)
04/2022 - 02/2019
2Asthenia
03/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

41Immune Checkpoint InhibitorsIBA
11/2022 - 04/2016
31Biomarkers (Surrogate Marker)IBA
02/2022 - 12/2009
21Sunitinib (Sutent)FDA Link
01/2022 - 01/2015
19cabozantinibIBA
10/2022 - 01/2016
16Tyrosine Kinase InhibitorsIBA
02/2022 - 05/2014
15enzalutamideIBA
05/2022 - 07/2013
15Biological ProductsIBA
01/2021 - 03/2014
14NivolumabIBA
10/2022 - 10/2018
12Androgen Receptors (Androgen Receptor)IBA
02/2022 - 01/2015
12Hormones (Hormone)IBA
01/2022 - 12/2009
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 03/2014
10Docetaxel (Taxotere)FDA Link
03/2020 - 01/2015
8pembrolizumabIBA
04/2022 - 01/2018
8Pharmaceutical PreparationsIBA
01/2022 - 03/2014
7Abiraterone AcetateIBA
08/2019 - 07/2013
6IpilimumabIBA
10/2022 - 11/2015
6Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022 - 01/2020
6Axitinib (AG 013736)IBA
01/2022 - 11/2015
6Monoclonal AntibodiesIBA
01/2022 - 07/2015
6PlatinumIBA
01/2022 - 12/2009
6atezolizumabIBA
10/2020 - 10/2017
6abirateroneIBA
06/2020 - 01/2015
6Cell-Free Nucleic AcidsIBA
01/2020 - 01/2018
5AntigensIBA
01/2022 - 01/2016
5pazopanibFDA Link
01/2022 - 01/2015
5AndrogensIBA
10/2021 - 01/2018
5DNA (Deoxyribonucleic Acid)IBA
05/2021 - 01/2012
5Hemoglobins (Hemoglobin)IBA
12/2019 - 01/2015
5EverolimusFDA Link
02/2019 - 01/2015
5Analgesics (Analgesic Drugs)IBA
01/2010 - 01/2004
5Polymethyl Methacrylate (Sol)IBA
07/2008 - 01/2004
4LigandsIBA
02/2022 - 06/2019
4Circulating Tumor DNAIBA
05/2021 - 01/2020
4Brain Natriuretic Peptide (Natrecor)FDA Link
05/2021 - 07/2016
4cabazitaxelFDA Link
01/2020 - 07/2013
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016 - 03/2014
3CreatinineIBA
05/2022 - 11/2020
3apalutamideIBA
05/2022 - 10/2021
3Sorafenib (BAY 43-9006)FDA Link
04/2022 - 01/2015
3Radium-223IBA
02/2022 - 07/2013
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2011
3CytokinesIBA
01/2021 - 08/2016
3avelumabIBA
12/2020 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2015
3Death Domain ReceptorsIBA
01/2020 - 03/2018
3MicroRNAs (MicroRNA)IBA
01/2020 - 10/2017
3ErbB Receptors (EGF Receptor)IBA
02/2015 - 12/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2022 - 01/2022
2Proton Pump InhibitorsIBA
05/2022 - 01/2022
2lenvatinibIBA
04/2022 - 01/2022

Therapy/Procedure

108Therapeutics
11/2022 - 01/2004
47Castration
05/2022 - 07/2013
41Immunotherapy
12/2022 - 01/2015
27Drug Therapy (Chemotherapy)
11/2022 - 09/2004
12Stents
11/2022 - 06/2013
8Radiotherapy
04/2022 - 01/2004
8Vertebroplasty
10/2014 - 09/2004
7Nephrectomy
01/2020 - 02/2015
6Precision Medicine
01/2020 - 01/2015
5Kyphoplasty
11/2005 - 01/2004
4Adjuvant Chemotherapy
01/2022 - 12/2009
3Catheters
06/2022 - 05/2016
3Length of Stay
01/2019 - 07/2005